High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma

International Journal of Clinical Oncology

Volumn 19, Issue 3, 2014, Pages 536-543

  Nishida, Yoshihiro ^a   Tsukushi, Satoshi ^a   Urakawa, Hiroshi ^a   Sugiura, Hideshi ^b   Nakashima, Hiroatsu ^b   Yamada, Yoshihisa ^c   Ishiguro, Naoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Nagoya Memorial Hospital   (Japan)

Author keywords

Alveolar type; Distant metastasis; In transit metastasis; Lymph node; Rhabdomyosarcoma

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IN-TRANSIT METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REGIONAL METASTASIS; RHABDOMYOSARCOMA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; INFANT; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RHABDOMYOSARCOMA, ALVEOLAR; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INFANT; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RHABDOMYOSARCOMA, ALVEOLAR; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903266413     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0571-4     Document Type: Article

References (24)

1. Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol official J Am Soc Clin Oncol 19:3091-3102 (Pubitemid 32567502)
2. Pappo AS, Anderson JR, Crist WM et al (1999) Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol 17:3487-3493 (Pubitemid 29517919)
3. Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol Off J Am Soc Clin Oncol 23:2618-2628. doi:10.1200/JCO.2005.08.130 (Pubitemid 46179450)
4. Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42:64-73. doi:10.1002/pbc.10441 (Pubitemid 38173459)
5. Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol Off J Am Soc Clin Oncol 26:2384-2389. doi:10.1200/JCO.2007.14.7207
6. Carli M, Colombatti R, Oberlin O et al (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol Off J Am Soc Clin Oncol 22:4787-4794. doi:10.1200/JCO.2004.04.083
7. Neville HL, Andrassy RJ, Lobe TE et al (2000) Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 35:317-321 (Pubitemid 30082591)
8. La TH, Wolden SL, Rodeberg DA et al (2011) Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:1151-1157. doi:10.1016/j.ijrobp.2010.03.050
9. Nishida Y, Tsukushi S, Urakawa H et al (2011) Difficulties to detect in-transit lymphatic metastasis in patients with rhabdomyosarcoma of the extremity: in regard to La et al. (Int J Radiat Oncol Biol Phys 2011;80:1151-1157). Int J Radiat Oncol Biol Phys 81:606; author reply 606. doi:10.1016/j.ijrobp.2011.04.061
10. Nishida Y, Tsukushi S, Yamada Y et al (2011) Recurrent alveolar rhabdomyosarcoma with prior surgery and radiotherapy: altered lymphatic drainage limits the reliability of sentinel lymph node biopsy. J Pediatr Hematol Oncol 33:e26-e28. doi:10.1097/MPH.0b013e3181faf857
11. Paulino AC, Pappo A (2009) Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatr Blood Cancer 53:1332-1333. doi:10.1002/pbc.22252
12. Viswanathan AN, Grier HE, Litman HJ et al (2004) Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys 58:1208-1214. doi:10.1016/j.ijrobp.2003.08.027 (Pubitemid 38314806)
13. Nishida Y, Yamada Y, Tsukushi S et al (2005) Sentinel lymph node biopsy reveals a positive popliteal node in clear cell sarcoma. Anticancer Res 25:4413-4416 (Pubitemid 41729488)
14. Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol Off J Am Soc Clin Oncol 25:5435-5441. doi:10.1200/JCO.2007. 12.2473 (Pubitemid 350232220)
15. Ben Arush MW, Bar Shalom R, Postovsky S et al (2006) Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. J Pediatr Hematol Oncol 28:440-445. doi:10.1097/01.mph.0000212949.12856.02 (Pubitemid 44114552)
16. Wright S, Armeson K, Hill EG et al (2012) The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg 204:428-433. doi:10.1016/j.amjsurg.2011.12.019
17. Chisholm JC, Marandet J, Rey A et al (2011) Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol Off J Am Soc Clin Oncol 29:1319-1325. doi:10.1200/JCO.2010.32.1984
18. Dantonello TM, Int-Veen C, Winkler P et al (2008) Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol Off J Am Soc Clin Oncol 26:406-413. doi:10.1200/JCO.2007.12.2382 (Pubitemid 351171692)
19. Wharam MD, Meza J, Anderson J et al (2004) Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol Off J Am Soc Clin Oncol 22:1902-1908. doi:10.1200/JCO.2004.08.124 (Pubitemid 41095182)
20. Rodeberg DA, Garcia-Henriquez N, Lyden ER et al (2011) Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 29:1304-1311. doi:10.1200/JCO.2010.29.4611
21. Kayton ML, Delgado R, Busam K et al (2008) Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer 112:2052-2059. doi:10.1002/cncr.23403 (Pubitemid 351574082)
22. McMulkin HM, Yanchar NL, Fernandez CV et al (2003) Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int 19:453-456. doi:10.1007/s00383-003- 0956-y (Pubitemid 37092741)
23. Mazzoleni S, Bisogno G, Garaventa A et al (2005) Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 104:183-190. doi:10.1002/cncr.21138 (Pubitemid 40847767)
24. Meza JL, Anderson J, Pappo AS et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 24:3844-3851. doi:10.1200/JCO.2005.05.3801 (Pubitemid 46630730)